Filing Details
- Accession Number:
- 0001437749-15-001050
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-22 18:15:07
- Reporting Period:
- 2015-01-20
- Filing Date:
- 2015-01-22
- Accepted Time:
- 2015-01-22 18:15:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1386858 | Hyperion Therapeutics Inc | HPTX | Pharmaceutical Preparations (2834) | 611512713 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1554403 | A Christine Nash | C/O Hyperion Therapeutics, Inc. 2000 Sierra Point Parkway, Suite 400 Brisbane CA 94005 | Svp & Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-01-20 | 2,500 | $24.36 | 31,403 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-01-20 | 2,500 | $25.27 | 28,903 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 15, 2014.
Billionaire Hedge Funds
